WHITE PAPER
Deciphering Glioma Patient Subpopulations Using NetraAI: Exploring an Association to Human Papillomavirus (HPV)
Currently, oligodendrogliomas (OGs) are stratified into three molecular subgroups on the basis of IDH mutation and 1p/19q co-deletion. Amongst 1p/19q co-deleted OG tumors, there is molecular heterogeneity related to EGFR, PTEN, 10q deletion, and several other markers...
Leveraging Large Language Models with NetraAI for Clinical Trial De-Risking: Launching NetraGPT
NetraAI represents a distinctive, Good Clinical Practice (GCP)-authenticated machine learning architecture that offers an accessible interface for researchers to engage with consolidated multimodal datasets. This empowers sponsors to uncover explainable patient...
Discovery of Unique Genetic Subtypes Contributing to Heterogeneity in Alzheimer’s Disease Progression Using NetraAI
Alzheimer’s disease (AD) is a neurodegenerative disease that contributes to 60-70% of all dementia cases and is characterized by neuronal cell damage and cognitive decline.1 Currently, drugs for AD target symptom control and there is no effective curative therapy for...